In this session, presenters discussed new drugs, new data, and new insights into acne and rosacea. Guy Webster, MD, PhD began his presentation by reviewing the case of a 17-year-old patient who experienced myalgia while taking isotretinoin, then elaborated on isotretinoin and muscle damage and how he handles these cases. He also reviewed the very […]
Maui Derm’s panel of leading authorities discussed a number of topics related to psoriasis, including the “metabolic” impact of psoriasis, new topical and systemic drugs in 2019, psoriatic arthritis, and the immunology and genetics of psoriasis. Andrew Blauvelt, MD, MBA, focused his presentation on new translational psoriasis research. Dr. Blauvelt discussed important clinical questions in […]
In this session, Maui Derm’s expert panel of dermatologists covered a wide range of topics in pediatric dermatology. Among those experts were Sheila Fallon-Friedlander, MD, and Ilona Frieden, MD. Dr. Fallon-Friedlander began her presentation with a discussion of rare cases of Spitz nevi in children and strategies when encountering Spitz nevi in pediatric patients under […]
In this session, several challenging clinical cases involving pigmented lesions that challenged our experts were presented. Critical issues vital to the practicing dermatologist were discussed, including congenital and Spitz nevi, management of dysplastic/atypical nevi, genetic testing and surgical management of melanoma, and therapies for metastatic melanoma. Session moderator Hensin Tsao, MD, PhD discussed the clinical […]
In the first cutaneous oncology session of the meeting, George Martin, MD, Brian Berman, MD, PhD, Ted Rosen, MD, and Neal Bhatia, MD provided attendees with their presentation, Actinic Keratosis Update and Pearls 2019. To start the presentation, the importance of treating every AK due to the inability to predict which AKs will eventuate into […]
Hana hou! The “Ted and Neal Show” once again entertained and educated attendees about new drugs and therapies in dermatology and how we will be using them in 2019. Drs. Rosen and Bhatia discussed halobetasol (HP) for the treatment of psoriasis, including a study comparing HP (0.01%) lotion versus HP cream (0.05%). In addition, they […]
Based on the Maui Derm 2018 presentation by Joel M. Gelfand MD, MSCE, FAAD, from University of Pennsylvania Perelman School of Medicine, Philadelphia Pennsylvania Article by Jo Ann LeQuang and the Journal of Clinical and Aesthetic Dermatology Medical literature on the topic of psoriasis comorbidities has been rapidly expanding since around the turn of the […]
Based on the Maui Derm 2018 presentation by Craig L. Leonardi, MD, Associate Clinical Professor of Dermatology, St. Louis University Medical School, St. Louis, Missouri Article by Jo Ann LeQuang and the Journal of Clinical and Aesthetic Dermatology Cytokines, those small proteins that regulate specific activities of a wide range of immunocompetent cells, are only […]
Based on the Maui Derm 2018 presentation by Andrew Blauvelt, MD, MBA, Oregon Medical Research Center, Portland, Oregon Article by Jo Ann LeQuang and the Journal of Clinical and Aesthetic Dermatology Psoriasis is caused by the complex interplay of four factors: autoantigens, environmental antigens, genetics, and the immune system. Autoinflammation, an inflammatory state not mediated […]
Based on the Maui Derm 2018 presentation by Arthur Kavanaugh, MD, Professor of Medicine and Director of the Center for Innovative Therapy (CIT) at University of California in San Diego, California Article by Jo Ann LeQuang and the Journal of Clinical and Aesthetic Dermatology Psoriasis is the most prevalent auto-immune disease in the […]
Administrative Office
Maui Derm
161 Wailea Ike Place, Suite A-104
Kihei, HI 96753
Stay Connected
Sign up to receive updates about upcoming meetings.